{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:11:37Z","timestamp":1789517497911,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1016\/j.jaci.2004.05.070","type":"journal-article","created":{"date-parts":[[2004,10,12]],"date-time":"2004-10-12T12:41:28Z","timestamp":1097584888000},"page":"838-844","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":161,"title":["Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis"],"prefix":"10.1016","volume":"114","author":[{"given":"Claus","family":"Bachert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Bousquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Walter","family":"Canonica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen R.","family":"Durham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludger","family":"Klimek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquim","family":"Mullol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul B.","family":"Van Cauwenberge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevi\u00e8ve","family":"Van Hamm\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2004.05.070_bib1","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1017\/S0022215100142380","article-title":"The prevalence of allergic rhinosinusitis: a review","volume":"112","author":"Jones","year":"1998","journal-title":"J Laryngol Otol"},{"key":"10.1016\/j.jaci.2004.05.070_bib2","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2500\/108854100778249088","article-title":"Allergic rhinitis update: epidemiology and natural history","volume":"21","author":"Bellanti","year":"2000","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaci.2004.05.070_bib3","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1067\/mai.2001.118891","article-title":"Allergic rhinitis and its impact on asthma","volume":"108","author":"Bousquet","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.05.070_bib4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2500\/105065897782537142","article-title":"Treatment strategies designed to minimize medical complications of allergic rhinitis","volume":"11","author":"Fireman","year":"1997","journal-title":"Am J Rhinol"},{"key":"10.1016\/j.jaci.2004.05.070_bib5","doi-asserted-by":"crossref","first-page":"S386","DOI":"10.1016\/S0091-6749(98)70227-1","article-title":"Impact of upper respiratory allergic diseases on quality of life","volume":"101","author":"Juniper","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.05.070_bib6","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S1081-1206(10)62543-4","article-title":"Quality of life in patients with allergic rhinitis","volume":"85","author":"Thompson","year":"2000","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2004.05.070_bib7","doi-asserted-by":"crossref","first-page":"891","DOI":"10.2165\/00019053-200119090-00001","article-title":"Impact of allergic rhinitis treatment on quality of life","volume":"19","author":"Tripathi","year":"2001","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jaci.2004.05.070_bib8","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2500\/108854196778996895","article-title":"Learning impairment and allergic rhinitis","volume":"17","author":"Simons","year":"1996","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaci.2004.05.070_bib9","first-page":"35","article-title":"Costs of hay fever in the United States in 1990","volume":"73","author":"McMenamin","year":"1994","journal-title":"Ann Allergy"},{"issue":"suppl 5","key":"10.1016\/j.jaci.2004.05.070_bib10","doi-asserted-by":"crossref","first-page":"S201","DOI":"10.1067\/mai.2000.110151","article-title":"Epidemiologic evidence for asthma and rhinitis comorbidity","volume":"106","author":"Leynaert","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.05.070_bib11","first-page":"3","article-title":"Epidemiology of rhinitis and asthma","volume":"28","author":"Lundback","year":"1998","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2004.05.070_bib12","doi-asserted-by":"crossref","first-page":"S773","DOI":"10.1016\/S0091-6749(97)70126-X","article-title":"Overview of comorbid associations of allergic rhinitis","volume":"99","author":"Spector","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.05.070_bib13","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1034\/j.1398-9995.2002.23625.x","article-title":"Allergic rhinitis and its impact on asthma: in collaboration with the World Health Organisation: executive summary of the workshop report","volume":"57","author":"Bousquet","year":"2002","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2004.05.070_bib14","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1034\/j.1398-9995.2003.00105.x","article-title":"Links between rhinitis and asthma","volume":"58","author":"Bousquet","year":"2003","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2004.05.070_bib15","first-page":"305","article-title":"Efficacy and safety of levocetirizine in seasonal allergic rhinitis","volume":"55","author":"Leynadier","year":"2001","journal-title":"Acta Otorhinolarygol Belg"},{"key":"10.1016\/j.jaci.2004.05.070_bib16","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1034\/j.1398-9995.2001.00204.x","article-title":"Comparison of the effects of levocetirizine and loratadine on histamine-induced wheal, flare, and itch in human skin","volume":"56","author":"Clough","year":"2001","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2004.05.070_bib17","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1034\/j.1398-9995.2001.00726.x","article-title":"A randomized, double-blind, crossover comparison among cetirizine, levocetirizine, and ucb 28557 on histamine-induced cutaneous responses in healthy adult volunteers","volume":"56","author":"Devalia","year":"2001","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2004.05.070_bib18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1046\/j.1365-2125.2002.01611.x","article-title":"Lack of effect of single and repeated doses of levocetirizine, a new antihistamine drug, on cognitive and psychomotor functions in healthy volunteers","volume":"54","author":"Gandon","year":"2002","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jaci.2004.05.070_bib19","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S1081-1206(10)61995-3","article-title":"A double-blind randomised single-dose, crossover comparison of levocetrirzine with ebastine, fexofenadine, loratadine, mizolastine and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects","volume":"88","author":"Grant","year":"2002","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2004.05.070_bib20","first-page":"1","article-title":"Cetirizine and levocetirizine inhibit eotaxin-induced eosinophil transendothelial migration through human dermal or lung microvascular endothelial cells","volume":"32","author":"Thompson","year":"2002","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2004.05.070_bib21","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1034\/j.1398-9995.2001.00919.x","article-title":"Generic or disease-specific quality of life scales to characterize health status in allergic rhinitis?","volume":"56","author":"Kremer","year":"2001","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2004.05.070_bib22","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1034\/j.1398-9995.2001.00852.x","article-title":"Health-related quality of life assessment in young adults with seasonal allergic rhinitis","volume":"56","author":"Majani","year":"2001","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2004.05.070_bib23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2222.1991.tb00807.x","article-title":"Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis","volume":"21","author":"Juniper","year":"1991","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2004.05.070_bib24","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0091-6749(96)70155-0","article-title":"Improvement of quality of life by treatment with cetirizine in patients with perennial allergic rhinitis as determined by a French version of the SF-36 questionnaire","volume":"98","author":"Bousquet","year":"1996","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.05.070_bib25","series-title":"SF-36 Health survey: manual and interpretation guide","author":"Ware","year":"1993"},{"key":"10.1016\/j.jaci.2004.05.070_bib26","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0091-6749(96)70135-5","article-title":"Interpretation of rhinoconjunctivitis quality of life questionnaire data","volume":"98","author":"Juniper","year":"1996","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.05.070_bib27","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1002\/1097-0258(20001215)19:23<3219::AID-SIM623>3.0.CO;2-P","article-title":"Analysis of cost data in randomized trials: an application of the non-parametric bootstrap","volume":"19","author":"Barber","year":"2000","journal-title":"Stat Med"},{"key":"10.1016\/j.jaci.2004.05.070_bib28","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0091-6749(95)70235-0","article-title":"Minimal persistent inflammation is present at mucosal level in patients with asymptomatic rhinitis and mite allergy","volume":"96","author":"Ciprandi","year":"1995","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.05.070_bib29","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S1081-1206(10)62230-2","article-title":"Long-term cetirizine treatment reduces allergic symptoms and drug prescriptions in children with mite allergy","volume":"87","author":"Ciprandi","year":"2001","journal-title":"Ann Allergy Asthma Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674904016768?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674904016768?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:54:39Z","timestamp":1758776079000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674904016768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["S0091674904016768"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2004.05.070","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2004,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2004.05.070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 American Academy of Allergy, Asthma and Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}